Limited Submission Opportunities
(Applications through UCSF Limited Submission Program)
- Internal deadline: April 3, 2024
NIH NIGMS Collaborative Program Grant for Multidisciplinary Teams (RM1)
Purpose: To support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS.
Intramural Funding Opportunities
For questions about intramural awards, please contact Meredith Donnelly.
- Deadline: March 22, 2024
CRISPR Cures for Cancer RFP
The CRISPR Cures for Cancer Initiative requests proposals that support our vision of a future of precise, genetically engineered, immune cell therapies accessible to patients across the full range of human cancers. We seek proposals for high-risk, high-reward projects developing or applying genomic technologies to the understanding and treatment of human cancer using next-generation cell-based therapies. Proposals should take account of the Initiative long-term goal of accelerating progress to cancer cures. - Deadline: March 31, 2024
HDFCCC Cancer Control Program RFA
The Cancer Control Program is requesting applications from active Cancer Control Program members for pilot research projects.
Foundations/Other Sources
- Deadline: Apr 18, 2024
Gateway for Cancer Research Grant Opportunities
Gateway for Cancer Research funds early phase investigator-initiated oncology trials focusing on: new investigational therapies, new indications, de-escalation of treatment, mitigation of treatment toxicity, predictive biomarkers (with a therapeutic component), and integrative medicine within the overall research areas of Biomarkers (prognostic or predictive with supportive treatment), Gene Therapy, Basket Trials, Immunotherapy, and Targeted Therapies. [UCSF contact for questions: [email protected]] - LOI Deadline: Apr 29, 2024
The Mark Foundation Emerging Leader Awards
Supports innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. - Deadline: May 13, 2024
Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA) for Early-Stage Investigator Physicians
Winn CDA is a 2-year program designed to support the career development of early-stage investigator physicians who are underrepresented in medicine (URiM) or who have a demonstrated commitment to increasing diversity in clinical research. (Cancer Center members may reach out to Robbie Díaz at [email protected] to request support with their applications.) - Deadline: May 15, 2024
Laboratory for Genomics Research (LGR) Innovation Award
The Laboratory for Genomics Research (LGR) Innovation Awards program aims to support early-stage technology development projects that could mature into future UC-LGR collaborative projects. Innovation Awards are one-year research grants to support labs at the UCSF and UC Berkeley campuses with an interest in developing highly innovative ideas into early proofs of concept across the field of functional genomics and CRISPR/Cas-based tool development. The goal for these awards is to support the development of novel platform technologies, disease-related model systems, and the application of these to functional genomics screens. The award is open to Faculty or faculty-equivalent status with primary appointments at UC San Francisco and UC Berkeley.
NIH Announcements
If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.
- Due Apr 5: Administrative Supplements for P30 Cancer Centers Support Grants to Stimulate Research in HIV/AIDS Cancer Research Projects at NCI-Designated Cancer Centers
- Due Apr 5: Administrative Supplements for P30 Cancer Centers Support Grants to Stimulate Research in Immunotherapy and Tumor Microenvironment in HIV/AIDS Cancer Patients at NCI-Designated Cancer Centers
- Due Apr 5: Administrative Supplements for P30 Cancer Centers Support Grants to Stimulate Research in HIV-Associated Cancers in Aging Populations
- Due Sept 6: NCI Administrative Supplements to Support Cancer Disparity Collaborative Research
To view NCI funding opportunities, search here